Clinical Trial
. 2003 Jan;48(1):280-1; author reply 281-2.
doi: 10.1002/art.10716.
Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al
- PMID: 12528144
- DOI: 10.1002/art.10716
Item in Clipboard
Clinical Trial
Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al
Arthritis Rheum.
2003 Jan.
No abstract available
Comment in
-
Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen.Arthritis Rheum. 2004 Jan;50(1):337-8; author reply 338. doi: 10.1002/art.11498. Arthritis Rheum. 2004. PMID: 14730639 No abstract available.
Comment on
-
Anti-Ro/SSA antibodies and congenital heart block: necessary but not sufficient.Arthritis Rheum. 2001 Aug;44(8):1723-7. doi: 10.1002/1529-0131(200108)44:8<1723::AID-ART305>3.0.CO;2-0. Arthritis Rheum. 2001. PMID: 11508420 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
